Back to search

Article

SLCs contribute to endocrine resistance in breast cancer: role of SLC7A5 (LAT1)

2019-02-21

Abstract excerpt

Resistance to endocrine therapies remains a major challenge for the successful management of patients with estrogen receptor-positive (ER+) breast cancers. Central to the development of resistance is the adaptive reprogramming of cellular metabolism in response to treatment. Solute carriers (SLCs) play a key role in metabolic reprogramming by transporting sugars, amino acids, and other nutrients and regulating the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
437ef95f-9e95-52e7-90c7-239f7a19ff91
DOI
10.1101/555342
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SLCs contribute to endocrine resistance in breast cancer: role of SLC7A5 (LAT1)DOI 10.1101/555342
Select a neighboring publication to make it the new centre.